{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:30:31Z","timestamp":1792726231730,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T00:00:00Z","timestamp":1411603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-711","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T07:01:47Z","timestamp":1411628507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy"],"prefix":"10.1186","volume":"14","author":[{"given":"Sofie","family":"De Langhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mulliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv","family":"Veldeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Remouchamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"van Greveling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Gilsoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"De Schepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"De Ruyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"De Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Thierens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"issue":"9804","key":"4904_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"Early Breast Canc Trialists C","year":"2011","unstructured":"Early Breast Canc Trialists C: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011, 378 (9804): 1707-1716.","journal-title":"Lancet"},{"issue":"5","key":"4904_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1188\/11.CJON.481-492","volume":"15","author":"D Feight","year":"2011","unstructured":"Feight D, Baney T, Bruce S, McQuestion M: Putting evidence into practice: evidence-based interventions for radiation dermatitis. Clin J Oncol Nurs. 2011, 15 (5): 481-492. 10.1188\/11.CJON.481-492.","journal-title":"Clin J Oncol Nurs"},{"issue":"3","key":"4904_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/sj.bjc.6605182","volume":"101","author":"GA Tanteles","year":"2009","unstructured":"Tanteles GA, Whitworth J, Mills J, Peat I, Osman A, McCann GP, Chan S, Barwell JG, Talbot CJ, Symonds RP: Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer?. Br J Cancer. 2009, 101 (3): 403-409. 10.1038\/sj.bjc.6605182.","journal-title":"Br J Cancer"},{"issue":"1","key":"4904_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-006-9480-9","volume":"106","author":"C Lilla","year":"2007","unstructured":"Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J: Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat. 2007, 106 (1): 143-150. 10.1007\/s10549-006-9480-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4904_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ijrobp.2012.01.069","volume":"84","author":"LMM Keller","year":"2012","unstructured":"Keller LMM, Sopka DM, Li TY, Klayton T, Li JS, Anderson PR, Bleicher RJ, Sigurdson ER, Freedman GM: Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the fox chase cancer center experience. Int J Radiat Oncol Biol Phys. 2012, 84 (4): 881-887. 10.1016\/j.ijrobp.2012.01.069.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"4904_CR6","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","volume":"26","author":"JP Pignol","year":"2008","unstructured":"Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TTT, Truong P, Ackerman I, Paszat L: A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008, 26 (13): 2085-2092. 10.1200\/JCO.2007.15.2488.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4904_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/01.coc.0000197661.09628.03","volume":"29","author":"GM Freedman","year":"2006","unstructured":"Freedman GM, Anderson PR, Li JS, Eisenberg DF, Hanlon AL, Wang L, Nicolaou N: Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol-Cancer Clinical Trials. 2006, 29 (1): 66-70.","journal-title":"Am J Clin Oncol-Cancer Clinical Trials"},{"issue":"2","key":"4904_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0167-8140(94)90063-9","volume":"33","author":"AM Moody","year":"1994","unstructured":"Moody AM, Mayles WPM, Bliss JM, Ahern RP, Owen JR, Regan J, Broad B, Yarnold JR: The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol. 1994, 33 (2): 106-112. 10.1016\/0167-8140(94)90063-9.","journal-title":"Radiother Oncol"},{"issue":"4","key":"4904_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/bjc.2012.290","volume":"107","author":"CJ Talbot","year":"2012","unstructured":"Talbot CJ, Tanteles GA, Barnett GC, Burnet NG, Chang-Claude J, Coles CE, Davidson S, Dunning AM, Mills J, Murray RJS, Popanda O, Seibold P, West CML, Yarnold JR, Symonds RP: A replicated association between polymorphisms near TNF alpha and risk for adverse reactions to radiotherapy. Br J Cancer. 2012, 107 (4): 748-753. 10.1038\/bjc.2012.290.","journal-title":"Br J Cancer"},{"issue":"5","key":"4904_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3109\/09553002.2013.765055","volume":"89","author":"JH Kim","year":"2013","unstructured":"Kim JH, Kolozsvary AJJ, Jenrow KA, Brown SL: Mechanisms of radiation-induced skin injury and implications for future clinical trials. Int J Radiat Biol. 2013, 89 (5): 311-318. 10.3109\/09553002.2013.765055.","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"4904_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2217\/pgs.10.186","volume":"12","author":"BS Rosenstein","year":"2011","unstructured":"Rosenstein BS: Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. Pharmacogenomics. 2011, 12 (2): 267-275. 10.2217\/pgs.10.186.","journal-title":"Pharmacogenomics"},{"issue":"2","key":"4904_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.radonc.2011.05.007","volume":"99","author":"RJS Murray","year":"2011","unstructured":"Murray RJS, Tanteles GA, Mills J, Perry A, Peat I, Osman A, Chan S, Cheung KL, Chakraborti PR, Woodings PL, Barwell JG, Symonds RP, Talbot CJ: Association between single nucleotide polymorphisms in the DNA repair gene LIG3 and acute adverse skin reactions following radiotherapy. Radiother Oncol. 2011, 99 (2): 231-234. 10.1016\/j.radonc.2011.05.007.","journal-title":"Radiother Oncol"},{"issue":"3","key":"4904_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.06.021","volume":"69","author":"T Suga","year":"2007","unstructured":"Suga T, Ishikawa A, Kohda M, Otsuka Y, Yamada S, Yamamoto N, Shibamoto Y, Ogawa Y, Nomura K, Sho K, Omura M, Sekiguchi K, Kikuchi Y, Michikawa Y, Noda S, Sagara M, Ohashi J, Yoshinaga S, Mizoe J, Tsuiti H, Iwakawa M, Imai T: Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2007, 69 (3): 685-693. 10.1016\/j.ijrobp.2007.06.021.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4904_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.ijrobp.2008.08.073","volume":"73","author":"J Werbrouck","year":"2009","unstructured":"Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K, Van Eijkeren M, Boterberg T, Willems P, Vral A, De Neve W, Thierens H: Acute normal tissue reactions in head-and-neck cancer patients treated with Imrt: influence of dose and association with genetic polymorphisms in DNA Dsb repair genes. Int J Radiat Oncol Biol Phys. 2009, 73 (4): 1187-1195. 10.1016\/j.ijrobp.2008.08.073.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4904_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/jmg.2007.053850","volume":"45","author":"LJ Worrillow","year":"2008","unstructured":"Worrillow LJ, Smith AG, Scott K, Andersson M, Ashcroft AJ, Dores GM, Glimelius B, Holowaty E, Jackson GH, Jones GL, Lynch CF, Morgan G, Pukkala E, Scott D, Storm HH, Taylor PR, Vyberg M, Willett E, Travis LB, Allan JM: Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma. J Med Genet. 2008, 45 (3): 142-146.","journal-title":"J Med Genet"},{"issue":"7246","key":"4904_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature07940","volume":"459","author":"DA Smirnov","year":"2009","unstructured":"Smirnov DA, Morley M, Shin E, Spielman RS, Cheung VG: Genetic analysis of radiation-induced changes in human gene expression. Nature. 2009, 459 (7246): 587-U120. 10.1038\/nature07940.","journal-title":"Nature"},{"key":"4904_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1748-717X-8-151","volume":"8","author":"T Mulliez","year":"2013","unstructured":"Mulliez T, Speleers B, Madani I, De Gersem W, Veldeman L, De Neve W: Whole breast radiotherapy in prone and supine position: is there a place for multi-beam IMRT?. Radiat Oncol. 2013, 8: 151-10.1186\/1748-717X-8-151.","journal-title":"Radiat Oncol"},{"issue":"9618","key":"4904_CR18","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"SM Bentzen","year":"2008","unstructured":"Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DAL, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR, Start Trialists G: The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008, 371 (9618): 1098-1107.","journal-title":"Lancet"},{"issue":"2","key":"4904_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.radonc.2013.08.040","volume":"108","author":"T Mulliez","year":"2013","unstructured":"Mulliez T, Veldeman L, van Greveling A, Speleers B, Sadeghi S, Berwouts D, Decoster F, Vercauteren T, De Gersem W, Van den Broecke R, De Neve W: Hypofractionated whole breast irradiation for patients with large breasts: A randomized trial comparing prone and supine positions. Radiother Oncol. 2013, 108 (2): 203-208. 10.1016\/j.radonc.2013.08.040.","journal-title":"Radiother Oncol"},{"issue":"2","key":"4904_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0360-3016(02)04143-3","volume":"55","author":"VM Remouchamps","year":"2003","unstructured":"Remouchamps VM, Vicini FA, Sharpe MB, Kestin LL, Martinez AA, Wong JW: Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys. 2003, 55 (2): 392-406. 10.1016\/S0360-3016(02)04143-3.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4904_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2156-9-36","volume":"9","author":"I Menashe","year":"2008","unstructured":"Menashe I, Rosenberg PS, Chen BE: PGA: power calculator for case\u2013control genetic association analyses. BMC Genet. 2008, 9: 36-","journal-title":"BMC Genet"},{"key":"4904_CR22","doi-asserted-by":"crossref","unstructured":"James ML, Lehman M, Hider PN, Jeffery M, Hickey BE, Francis DP: Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database Syst Rev. 2010, CD003860-11","DOI":"10.1002\/14651858.CD003860.pub3"},{"issue":"4","key":"4904_CR23","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ijrobp.2012.01.093","volume":"84","author":"R Hannan","year":"2012","unstructured":"Hannan R, Thompson RF, Chen Y, Bernstein K, Kabarriti R, Skinner W, Chen CC, Landau E, Miller E, Spierer M, Hong L, Kalnicki S: Hypofractionated whole-breast radiation therapy: does breast size matter?. Int J Radiat Oncol Biol Phys. 2012, 84 (4): 894-901. 10.1016\/j.ijrobp.2012.01.093.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4904_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/COC.0b013e31827b45b7","volume":"37","author":"KS Corbin","year":"2014","unstructured":"Corbin KS, Dorn PL, Jain SK, Al-Hallaq HA, Hasan Y, Chmura SJ: Hypofractionated radiotherapy does not increase acute toxicity in large-breasted women: results from a prospectively collected series. Am J Clin Oncol. 2014, 37 (4): 322-326. 10.1097\/COC.0b013e31827b45b7.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"4904_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.radonc.2010.12.012","volume":"100","author":"C Goldsmith","year":"2011","unstructured":"Goldsmith C, Haviland J, Tsang Y, Sydenham M, Yarnold J, Grp FT: Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?. Radiother Oncol. 2011, 100 (2): 236-240. 10.1016\/j.radonc.2010.12.012.","journal-title":"Radiother Oncol"},{"issue":"10","key":"4904_CR26","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.clon.2011.04.011","volume":"23","author":"GC Barnett","year":"2011","unstructured":"Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE: The cambridge breast intensity-modulated radiotherapy trial: patient- and treatment-related factors that influence late toxicity. Clin Oncol. 2011, 23 (10): 662-673. 10.1016\/j.clon.2011.04.011.","journal-title":"Clin Oncol"},{"issue":"1","key":"4904_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijrobp.2011.05.074","volume":"83","author":"PL Dorn","year":"2012","unstructured":"Dorn PL, Corbin KS, Al-Hallaq H, Hasan Y, Chmura SJ: Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients. Int J Radiat Oncol Biol Phys. 2012, 83 (1): 79-83. 10.1016\/j.ijrobp.2011.05.074.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4904_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1470-2045(10)70013-9","volume":"11","author":"D Azria","year":"2010","unstructured":"Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K, Moscardo CL, Lemanski C, Coelho M, Rosenstein B, Fenoglietto P, Crompton NEA, Ozsahin M: Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol. 2010, 11 (3): 258-265. 10.1016\/S1470-2045(10)70013-9.","journal-title":"Lancet Oncol"},{"issue":"16","key":"4904_CR29","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1200\/JCO.2008.17.9549","volume":"27","author":"MY Halyard","year":"2009","unstructured":"Halyard MY, Pisansky TM, Dueck AC, Suman V, Pierce L, Solin L, Marks L, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil SR, Perez EA: Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol. 2009, 27 (16): 2638-2644. 10.1200\/JCO.2008.17.9549.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4904_CR30","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/carcin\/bgr089","volume":"32","author":"N Whiffin","year":"2011","unstructured":"Whiffin N, Broderick P, Lubbe SJ, Pittman AM, Penegar S, Chandler I, Houlston RS: MLH1-93G\u2009>\u2009A is a risk factor for MSI colorectal cancer. Carcinogenesis. 2011, 32 (8): 1157-1161. 10.1093\/carcin\/bgr089.","journal-title":"Carcinogenesis"},{"issue":"3","key":"4904_CR31","doi-asserted-by":"publisher","first-page":"S679","DOI":"10.1016\/j.ijrobp.2012.07.1813","volume":"84","author":"M Janko","year":"2012","unstructured":"Janko M, Ontiveros F, Fitzgerald TJ, Deng A, DeCicco M, Rock KL: IL-1 Generated subsequent to radiation-induced tissue injury contributes to the pathogenesis of radiodermatitis. Int J Radiat Oncol Biol Phys. 2012, 84 (3): S679-S679.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-711\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:08:52Z","timestamp":1630562932000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4904"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-711","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]},"assertion":[{"value":"28 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"711"}}